Document Detail


Invasiveness as a barrier to self-monitoring of blood glucose in diabetes.
MedLine Citation:
PMID:  16120035     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: This study investigated the degree to which the invasive characteristic of glucose monitoring is a barrier to self-monitoring of blood glucose (SMBG). METHODS: A paper-and-pencil Measure of Invasiveness as a reason for Skipping SMBG (MISS) was created and administered to 339 people with diabetes. The correlations between MISS scores and actual SMBG frequency, percent adherence to SMBG recommendations, SMBG anxiety, SMBG burden, and knowledge of the importance of glycemic control for avoiding diabetes complications were each explored. RESULTS: On a scale of 0-28, the average MISS score was M = 4.3 (SD = 5.4, range 0-28). Fully 63% (nearly two-thirds) of respondents reported skipping SMBG because of the invasiveness of the procedure. MISS scores were negatively related to percent adherence to healthcare provider SMBG recommendations as measured by memory function of automated meters (Spearman's r= -0.47, P < 0.01). MISS scores were also negatively related to absolute SMBG frequency regardless of SMBG recommendations (Spearman's r= -0.11, P < 0.05). Correlation between the MISS and SMBG anxiety was significant (Spearman's r = 0.50, P < 0.01). With highly anxious participants deleted, the magnitude of the correlation was attenuated, but persisted (Spearman's r = 0.28, P < 0.01), suggesting that invasiveness is associated with SMBG anxiety even among patients without a blood or injection phobia. MISS scores were also correlated with the degree to which patients find routine and non-routine SMBG checks a burden (routine r = 0.38, P < 0.01; non-routine r = 0.45, P < 0.01). Results of Mann-Whitney U tests indicated higher MISS scores among participants with less knowledge about the importance of glycemic control in the development of diabetes vascular complications. CONCLUSIONS: Invasiveness is a common and serious barrier to SMBG. These findings suggest that people with diabetes would perform SMBG more frequently and have improved quality of life with non-invasive SMBG.
Authors:
Julie Wagner; Carl Malchoff; Gina Abbott
Related Documents :
2000365 - Portable blood glucose meters. teaching patients how to correctly monitor diabetes.
10337495 - Prediction of blood glucose levels in diabetic patients using a hybrid ai technique.
1892345 - Safe, stable, whole blood samples for quality assessment of glucose measurement by non-...
11762515 - Physiological influences on off-finger glucose testing.
10817875 - Screening for gestational diabetes: variation in guidelines.
22182635 - Traditional uses, phytochemistry and pharmacology of clerodendron glandulosum coleb - a...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Diabetes technology & therapeutics     Volume:  7     ISSN:  1520-9156     ISO Abbreviation:  Diabetes Technol. Ther.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-25     Completed Date:  2005-11-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100889084     Medline TA:  Diabetes Technol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  612-9     Citation Subset:  IM    
Affiliation:
Dept. of Behavioral Sciences and Community Health, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA. juwagner@uchc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anxiety*
Blood Glucose Self-Monitoring / adverse effects*
Diabetes Mellitus, Type 1 / blood,  drug therapy,  psychology*
Diabetes Mellitus, Type 2 / blood,  drug therapy,  psychology*
Fear*
Humans
Injections, Subcutaneous / adverse effects*
Insulin / administration & dosage,  therapeutic use
Middle Aged
Questionnaires
Chemical
Reg. No./Substance:
11061-68-0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alternative site self blood glucose testing is preferred by women with gestational diabetes.
Next Document:  Assessment of dose selection attributes with audible notification in insulin pen devices.